SCHEMBL1074693

SCHEMBL1074693

CC(C)OC(=O)C(N)CC(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BHMT Q93088 1/20 0.38
TSHR P16473 2/20 0.37
GABRP O00591 2/20 0.37
GABRD O14764 2/20 0.37
GABRA1 P14867 2/20 0.37
GABRB1 P18505 2/20 0.37
GABRG2 P18507 2/20 0.37
GABRB3 P28472 2/20 0.37
GABRA5 P31644 2/20 0.37
GABRA3 P34903 2/20 0.37
GABRA2 P47869 2/20 0.37
GABRB2 P47870 2/20 0.37
GABRA4 P48169 2/20 0.37
GABRE P78334 2/20 0.37
GABRA6 Q16445 2/20 0.37
GABRG1 Q8N1C3 2/20 0.37
GABRG3 Q99928 2/20 0.37
GABRQ Q9UN88 2/20 0.37
SLC7A5 Q01650 1/20 0.37
CACNA2D1 P54289 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1074694 1.00 BHMT (0.38) BHMTTSHRGABRPGABRDGABRA1
Hydrochloric Acid SCHEMBL7980115 0.98 BHMT (0.37) BHMTTSHRGABRPGABRDGABRA1
SCHEMBL28445648 0.85 BHMT (0.37) BHMTGABRPGABRDGABRA1GABRB1
SCHEMBL28445647 0.85 BHMT (0.37) BHMTGABRPGABRDGABRA1GABRB1
SCHEMBL25310359 0.83 BHMT (0.40) BHMTGABRPGABRDGABRA1GABRB1
SCHEMBL19491575 0.83 TDP1 (0.42) TSHRSLC7A5LMNAHCAR2GRIK1
SCHEMBL7781912 0.83 TSHR (0.37) TSHRSLC7A5LMNAHCAR2ALOX15
SCHEMBL6435729 0.83 LMNA (0.39) TSHRSLC7A5LMNASMN1; SMN2GRIK1
SCHEMBL6435735 0.83 LMNA (0.39) TSHRSLC7A5LMNASMN1; SMN2GRIK1
SCHEMBL7781916 0.83 TSHR (0.37) TSHRSLC7A5LMNAHCAR2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114478324-B Active compound and application thereof in side chain carboxyl compound protection 上海嘉莱多生物技术有限责任公司 2023-07-07 CN disclosed
CN-114478324-A Active compound and application thereof in side chain carboxyl compound protection 上海嘉莱多生物技术有限责任公司 2022-05-13 CN disclosed
CN-104169322-A Method for producing ring-opening metathesis polymer hydride, and resin composition ZEON CORP 2014-11-26 CN disclosed
CN-101495571-B Thermoplastic resin composition and molded body thereof MITSUI CHEMICALS, INC. (JP) 2012-02-08 CN disclosed
US-7902281-B2 Thermoplastic resin composition and molded article thereof MITSUI CHEMICALS, INC. (JP) 2011-03-08 US disclosed
EP-2050788-B1 THERMOPLASTIC RESIN COMPOSITION AND MOLDED BODY THEREOF MITSUI CHEMICALS INC (JP) 2011-01-05 EP disclosed
CN-101495571-A Thermoplastic resin composition and molded body thereof MITSUI CHEMICALS INC (JP) 2009-07-29 CN disclosed
US-20090186992-A1 THERMOPLASTIC RESIN COMPOSITION AND MOLDED ARTICLE THEREOF MITSUI CHEMICALS, INC (JP) 2009-07-23 US disclosed
EP-2050788-A1 THERMOPLASTIC RESIN COMPOSITION AND MOLDED BODY THEREOF Mitsui Chemicals, Inc. (JP) 2009-04-22 EP disclosed
EP-1135398-A1 CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION Monsanto Technology LLC (US) 2001-09-26 EP disclosed
US-6218563-B1 Cyanophosphonamides and method for preparation MONSANTO COMPANY 2001-04-17 US disclosed
WO-2000032611-A1 CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION MONSANTO TECHNOLOGY LLC (US) 2000-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090186992-A1 THERMOPLASTIC RESIN COMPOSITION AND MOLDED ARTICLE THEREOF TRIM59, TRIM4, MAP1LC3C BHMT 2274/4885TSHR 4386/4885GABRP 649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.